(Q44174479)

English

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study

scientific article published on 2 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study (English)

1 reference

Europe PubMed Central

30 November 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Takao Takahashi

1

object named as

Takao Takahashi

1 reference

Europe PubMed Central

30 November 2017

author name string

Yoshihisa Shibata

2

1 reference

Europe PubMed Central

30 November 2017

Yuichiro Tojima

3

1 reference

Europe PubMed Central

30 November 2017

Kenji Tsuboi

4

1 reference

Europe PubMed Central

30 November 2017

Eiji Sakamoto

5

1 reference

Europe PubMed Central

30 November 2017

Katsuyuki Kunieda

6

1 reference

Europe PubMed Central

30 November 2017

Hiroshi Matsuoka

7

1 reference

Europe PubMed Central

30 November 2017

Kazuyoshi Suzumura

8

1 reference

Europe PubMed Central

30 November 2017

Mikinori Sato

9

1 reference

Europe PubMed Central

30 November 2017

Tatsushi Naganuma

10

1 reference

Europe PubMed Central

30 November 2017

Junichi Sakamoto

11

1 reference

Europe PubMed Central

30 November 2017

Satoshi Morita

12

1 reference

Europe PubMed Central

30 November 2017

Ken Kondo

13

1 reference

Europe PubMed Central

30 November 2017

publication date

2 March 2012

1 reference

Europe PubMed Central

30 November 2017

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

30 November 2017

18

1 reference

Europe PubMed Central

30 November 2017

2

1 reference

Europe PubMed Central

30 November 2017

335-342

1 reference

Europe PubMed Central

30 November 2017

https://scigraph.springernature.com/pub.10.1007/s10147-012-0382-z

0 references

Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0382-Z

21 January 2018

Surgical therapy of hepatic colorectal metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of patients with untreated liver metastases from colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-012-0382-Z

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44174479&oldid=2108280813"